Prosecution Insights
Last updated: April 19, 2026

Sage Therapeutics Inc.

10 pending office actions

Portfolio Summary

10
Total Pending OAs
1
Final Rejections
9
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18557691 19-NOR C3,3-DISUBSTITUTED C21 -N-PYRAZOLYL STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION SHIM, DAVID M. 1626 Non-Final OA Oct 27, 2023
18550724 A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER ELENISTE, PIERRE PAUL 1622 Non-Final OA Sep 15, 2023
18546616 USE OF NEUROACTIVE STEROID FOR TREATMENT OF SEXUAL DYSFUNCTION CHICKS, ASHLI ARIANA 1626 Non-Final OA Aug 16, 2023
18349218 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF RODRIGUEZ-GARCIA, VALERIE 1621 Non-Final OA Jul 10, 2023
18216057 OXYSTEROLS AND METHODS OF USE THEREOF HOWELL, THEODORE R 1628 Final Rejection Jun 29, 2023
18201885 CYP46A1 INHIBITORS AND METHODS OF USE THEREOF MOU, LIYUAN 1628 Non-Final OA May 25, 2023
17993020 NEUROACTIVE STEROIDS AND THEIR METHODS OF USE HUI, SAN MING R 1627 Non-Final OA Nov 23, 2022
17947844 NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF KLINKEL, KORTNEY L 1627 Non-Final OA Sep 19, 2022
17579541 FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF CHANDRAKUMAR, NIZAL S 1625 Non-Final OA Jan 19, 2022
17620303 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS NOTTINGHAM, KYLE GREGORY 1621 Non-Final OA Dec 17, 2021

Managing Sage Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month